Show me the Data! Stanford’s Ibogaine Study Shows Major Breakthroughs for PTSD & Addiction.

A new study out of Stanford University is making waves in the mental health and addiction space—and for good reason. The findings show dramatic reductions in PTSD, depression, anxiety, and disability following a single treatment with ibogaine.

In this video, I break down the numbers and explore why this study—conducted in partnership with the non-profit Veterans Exploring Treatment Solutions (VETS)—is such a big deal. It’s not just the science that excites me. It’s the possibility this opens up for the veteran community and for anyone suffering from opioid use disorder or treatment-resistant trauma.

As a 24-year Marine Corps veteran, I’ve seen firsthand the limitations of conventional treatments. This research marks a hopeful shift—and one that deserves more public awareness and support. 📊

We’ll look at:

• The measurable outcomes from the Stanford study

• How ibogaine may offer transformational results

• What this could mean for future care models for veterans and beyond

This isn’t fringe science. It’s rigorous, peer-reviewed research—and it’s pointing us toward a future where healing looks very different than it has in the past.

🔔 Subscribe for updates on psychedelic policy, veteran advocacy, leadership, and systems of healing.